A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 1 August 2022) has been published and includes articles on:

Nebulised asthma rescue therapy in children: home use of nebulisers in paediatric asthma should be initiated and managed only by specialists
COVID-19 vaccines and medicines: updates for August 2022
Letters and medicine recalls sent to healthcare professionals in July 2022

To see the latest MHRA Drug Safety Updates in full, visit the GOV.uk website.

The post MHRA Drug Safety Update August 2022 appeared first on PSNC Website.